Alzheimer's Research & Therapy
Eighteen-month real-world outcomes of lecanemab treatment and transition to maintenance therapy in early Alzheimer’s disease
Study in peopleInterventions
Papers by Noa Bregman
3 results
- Journal of Parkinson's Disease
Cognitive and motor profiles in biologically defined Parkinson's and Alzheimer's disease
Study in peopleBiomarkers - AAIC 2025 Abstract
Lecanemab in Practice: Real‐World Data from a 6‐Month Follow‐Up in Early Alzheimer’s Disease
Trial in peopleInterventions